Azenta Life Sciences
Private Company
Total funding raised: $50M
Overview
Azenta Life Sciences is a strategic enabler in the life sciences value chain, offering a comprehensive portfolio that spans automated sample storage systems, consumables, cloud-based informatics (LIMS), and GENEWIZ multiomics services. Its strategy focuses on integrating hardware, software, and services to solve critical bottlenecks in biobanking, clinical trials, and cell & gene therapy. As a publicly traded company with a ~$1B valuation, Azenta has evolved through strategic acquisitions and organic growth to become a dedicated partner for pharmaceutical, biotech, and academic research organizations worldwide.
Technology Platform
An integrated ecosystem of automated sample storage hardware, tracking consumables, cloud-based informatics software (LIMS), and multiomics services, designed to manage the entire biological sample lifecycle.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Azenta competes with focused players in automated storage (Hamilton, Tecan), consumables (Thermo Fisher), LIMS (LabVantage), and multiomics services (Eurofins, Twist). Its primary advantage is its integrated, full-stack ecosystem, which creates switching costs and a 'one-stop-shop' value proposition.